What’s new

• Trident Techlabs abandoned a planned semiconductor acquisition after due diligence revealed financial risks.
• The company cut its growth target, guiding for a 30% CAGR in revenue, EBITDA, and PAT over three years.
• Management walked back earlier promises of balanced quarterly growth, citing government contract lumpiness.

Why it matters

The strategic pivot is a sharp reversal. A company that was pursuing a semiconductor deal and guiding ₹1,000 crore in five years now says both plans are off. The new target is more modest, and the loss of quarterly predictability is a direct hit to investor confidence in a small-cap name.

What we’re watching

• How the order book converts to revenue given the new caveat on lumpiness.
• Whether the DRDO and KSEB wins are repeatable or one-off injections.
• The impact on FY27 margins after a year of strategic spending dragged PAT down 47%.

The full read

Trident Techlabs just killed its semiconductor play. After due diligence flagged financial risks, management abandoned the acquisition entirely. The strategic reset goes further: the company scrapped its old guidance of reaching ₹1,000 crore in five years and now targets a 30% CAGR in revenue, EBITDA, and PAT over the next three. It also admitted quarterly revenue won't be predictable, citing lumpiness in government contracts. The operational numbers tell the story of the past strategy's cost. Revenue grew 27% in FY26, but profit fell 47% to ₹6 crore, hit by dollar headwinds and spending on the semiconductor and cybersecurity pushes. Order wins like the ₹17.73 crore DRDO contract and ₹26.95 crore KSEB deal show the core business still works. The question is whether the new, leaner plan can deliver faster than the old one. Management says it will.

Primary source: NSE